Author:
Allam Uday Sankar,Kamatham Shilpa,Adarsha Maraline,Jasmine Sk. Md.,Giri Prasad P. V.
Reference146 articles.
1. Abdelrahim M, Safe S (2005) Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol 68(2):317–329
2. Akiyama Y, Watkins N, Suzuki H, Jair KW, van Engeland M, Esteller M, …, Baylin SB (2003) GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol 23(23):8429–8439
3. Armaghany T, Wilson JD, Chu Q, Mills G (2012) Genetic alterations in colorectal cancer. Gastrointest Cancer Res: GCR 5(1):19
4. Armelao F, de Pretis G (2014) Familial colorectal cancer: a review. World J Gastroenterol: WJG 20(28):9292
5. Ashida R, Tominaga K, Sasaki E, Watanabe T, Fujiwara Y, Oshitani N, …, Arakawa T (2005) AP-1 and colorectal cancer. Inflammopharmacology 13(1):113–125